Patient Controlled Intravenous Analgesia with Oxycodone or Sufentanil After Hip Surgery: Study Protocol for a...

Area of Science:

• Anesthesiology
• Pharmacology
• Orthopedic Surgery

Background:

• Patient-controlled intravenous analgesia (PCIA) is crucial for managing hip surgery pain.
• Sufentanil PCIA provides effective analgesia but is associated with significant adverse effects.
• Oxycodone, a semi-synthetic opioid, shows promise for good pain relief with a potentially better safety profile.

Purpose of the Study:

• To compare the analgesic efficacy and safety of oxycodone PCIA versus sufentanil PCIA in hip surgery patients.
• To determine if equipotent doses of oxycodone can achieve similar pain control to sufentanil with reduced side effects.
• To provide evidence-based recommendations for postoperative pain management after hip surgery.

Main Methods:

• A multi-centered, randomized, controlled, open-label clinical trial.
• 570 hip surgery patients randomized 1:1 to receive either oxycodone PCIA or sufentanil PCIA.
• Primary outcome: resting numerical rating scale (NRS) pain scores at 2 hours post-surgery.

Main Results:

• The study is ongoing, and results are pending.
• Key secondary outcomes include postoperative nausea and vomiting (PONV), pain on movement, complications, mobilization, and length of stay.
• Data collection aims to comprehensively evaluate the efficacy and safety profiles of both analgesics.

Conclusions:

• This trial will offer critical evidence for selecting PCIA agents in hip surgery.
• Findings will inform postoperative pain management guidelines and recommendations.
• The study aims to optimize patient outcomes by balancing effective analgesia with minimized adverse effects.